
PureCycle Technologies, Inc.
PCTNASDAQIndustrialsIndustrial - Pollution & Treatment Controls
Previous close
$6.80
+$0.05 · +0.74%
PCT company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
11
Overpriced
Momentum
24
Weakening
Sentiment
66
Bullish
Risk resilience
21
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websitePureCycle Technologies, Inc. focuses on manufacturing high-quality, recycled polypropylene (PP). The company employs a proprietary and licensed technology that converts discarded PP materials into an exceptionally pure, regenerated resin. Through an advanced purification process, they meticulously eliminate color, odor, and other unwanted substances from plastic waste feedstock, thereby producing a resin comparable to newly manufactured virgin plastic. Established in 2015, the company maintains its corporate headquarters in Orlando, Florida.
- Industry
- Industrial - Pollution & Treatment Controls
- Sector
- Industrials
- Headquarters
- US
- CEO
- Dustin Olson
- Listed since
- Jul 14, 2020
- Employees
- 174
Market position
Day range
Current $6.80
52-week range
Current $6.80
- Open
- $6.70
- Previous close
- $6.75
- Volume
- 2.78M
- 0.55× average
- Average volume
- 5.09M
- Average daily volume
- Market cap
- 1.36B USD
- Beta
- 2.58
- Market reference 1
- 50-day average
- $7.2191
- -5.81% below average
- 200-day average
- $8.3766
- -18.82% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 2.16B USD
- EV / EBITDA
- -25.87×
- Earnings yield
- -11.85%
- Free cash flow yield
- -11.92%
Profitability & efficiency
- Return on equity
- -397.86%
- Return on assets
- -19.79%
- Return on invested capital
- -19.52%
Financial health
- Current ratio
- 2.26×
Financial statements
Income trends
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.36M USD | — | — | — | — |
| Cost of goods sold | 142.98M USD | 34.71M USD | 18.86M USD | 26.56M USD | 10.55M USD |
| Gross profit | −134.62M USD | −34.71M USD | −18.86M USD | −26.56M USD | −10.55M USD |
| Research and development | 5.93M USD | 3.38M USD | 6.61M USD | 1.09M USD | 1.41M USD |
| Selling, general, and administrative | 59.48M USD | 138.95M USD | 107.29M USD | 76.97M USD | 57.62M USD |
| Operating expenses | 31.74M USD | 110.67M USD | 95.04M USD | 54.76M USD | 59.03M USD |
| Interest income | 5.86M USD | 5.19M USD | 3.76M USD | 4.95M USD | 6.65K USD |
| Interest expense | 64.45M USD | 56.85M USD | 31.37M USD | 2.31M USD | 6.65M USD |
| Depreciation and amortization | 33.67M USD | 34.71M USD | 15.94M USD | 5.21M USD | 2.28M USD |
| Operating income | −166.37M USD | −145.38M USD | −113.9M USD | −81.32M USD | −69.58M USD |
| Net income | −182.57M USD | −289.14M USD | −101.72M USD | −84.75M USD | −77.5M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 36%
- 4 beats, 7 misses, 0 met estimates
- Average EPS surprise
- -64.83%
- 11 comparable reports
- Latest EPS result
- -0.8
- Estimate -0.29 · Miss by 175.86%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Recent analyst actions
PCT peers
ETFs holding PCT
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI36.27M0.00%2.3T USD0.03%$378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB26.25M0.01%183.4B USD0.03%$304.76+0.64%
iShares Russell 2000 ETFIWM25.2M0.03%81.62B USD0.19%$299.96+0.77%
Simplify Health Care ETFPINK23.75M6.24%380.8M USD0.51%$40.21+1.16%
Vanguard Morningstar Small-Cap Growth ETFVBK15.11M0.03%43.8B USD0.05%$358.65+0.70%
Vanguard Extended Market ETFVXF10.46M0.01%93.7B USD0.05%$245.53+0.82%
iShares Russell 2000 Growth ETFIWO9.25M0.06%15.16B USD0.24%$387.37+1.24%
Vanguard Russell 2000 ETFVTWO5.21M0.03%17.4B USD0.06%$121.25+0.74%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 36.27M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 26.25M
- Weight
- 0.01%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
iShares Russell 2000 ETFIWM- Market value
- 25.2M
- Weight
- 0.03%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Simplify Health Care ETFPINK- Market value
- 23.75M
- Weight
- 6.24%
- AUM
- 380.8M USD
- Expense ratio
- 0.51%
- Price / 1D
- $40.21+1.16%
Vanguard Morningstar Small-Cap Growth ETFVBK- Market value
- 15.11M
- Weight
- 0.03%
- AUM
- 43.8B USD
- Expense ratio
- 0.05%
- Price / 1D
- $358.65+0.70%
Vanguard Extended Market ETFVXF- Market value
- 10.46M
- Weight
- 0.01%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Russell 2000 Growth ETFIWO- Market value
- 9.25M
- Weight
- 0.06%
- AUM
- 15.16B USD
- Expense ratio
- 0.24%
- Price / 1D
- $387.37+1.24%
Vanguard Russell 2000 ETFVTWO- Market value
- 5.21M
- Weight
- 0.03%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25+0.74%
Continue in GoAI
Research PCTresearch.disclaimer





